Product Information
VARENICLINE STARTING MONTH BOX is a generic product labeled by Apotex Corp., priced at $0.3972 per EA under NDC 60505361504. Its NADAC has been published 139 times since Feb 7, 2024.
FDA first approved this application on Jan 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Apotex Corp.NDC
60505361504
Classification
Generic
Dosage Form
KIT
Route
ORAL
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA201962FDA Approved
1/25/2023
TE Code
AB
On Market Since
1/15/2024
Price Statistics
The NADAC for VARENICLINE STARTING MONTH BOX has been published 139 times since Feb 7, 2024, and over the history we have for it it has declined 89.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3972 per EA |
|---|---|
| All-time high | $3.7884 (Feb 14, 2024) |
| All-time low | $0.3972 (Sep 23, 2026) |
| 52-week high | $0.5229 |
| 52-week low | $0.3972 |
| Median price | $0.5618 |
| Average price | $0.9967 |
| Largest weekly change | +71.9% (Dec 18, 2024) |
| Weeks tracked | 139 |
| Tracking since | Feb 7, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the VARENICLINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
VARENICLINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VARENICLINE STARTING MONTH BOX?
The current National Average Drug Acquisition Cost (NADAC) for VARENICLINE STARTING MONTH BOX, manufactured by Apotex Corp., is $0.3972 per EA (NDC 60505361504), effective Sep 30, 2026.
How has the price of VARENICLINE STARTING MONTH BOX changed over time?
Over the history we have for it, the NADAC for VARENICLINE STARTING MONTH BOX has declined 89.5%. It has been tracked across 139 weekly CMS publications since Feb 7, 2024.
What are the highest and lowest recorded NADAC prices for VARENICLINE STARTING MONTH BOX?
Since Feb 7, 2024, the NADAC for VARENICLINE STARTING MONTH BOX has ranged from a low of $0.3972 (Sep 23, 2026) to a high of $3.7884 (Feb 14, 2024), with a median of $0.5618 per EA.
Are there cheaper alternatives to VARENICLINE STARTING MONTH BOX?
No other NADAC-published product currently shares the active ingredient and strength of VARENICLINE STARTING MONTH BOX in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VARENICLINE STARTING MONTH BOX?
VARENICLINE STARTING MONTH BOX (NDC 60505361504) is labeled by Apotex Corp., and CMS classifies it as a generic product.